Abstract: GPR64 antibody compositions are provided. These antibodies may be used for diagnosis or treatment of cancer, especially ovarian cancer, Ewing's sarcoma, uterine cancer, and other GPR64 expressing tumor types.
Type:
Grant
Filed:
December 19, 2003
Date of Patent:
October 2, 2007
Assignee:
PDL Biopharma, Inc.
Inventors:
Debbie Law, Qi Wang, Robert DuBridge, Vinay Bhaskar